Modeling Chelator Substituent Effects as Therapeutic Targets in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Computational Chemistry
• Pharmacology

Background:

• Neurodegenerative diseases, including Alzheimer's disease (AD), are linked to redox-active biometals in the central nervous system (CNS).
• These biometals generate reactive oxygen species (ROS) and promote amyloid-beta (Aβ) peptide aggregation, driving disease pathology.
• Chelation therapy offers a potential disease-modifying approach by targeting these metal ions.

Purpose of the Study:

• To investigate tetradentate Schiff base derivatives as potential chelators for neurodegenerative disease treatment.
• To explore the physicochemical properties influencing therapeutic efficacy, particularly metal chelate selectivity.
• To identify design modifications that enhance binding affinity and selectivity for therapeutic targets.

Main Methods:

• Density Functional Theory (DFT) studies were employed to analyze chelator candidates.
• Physicochemical properties, including binding affinity and selectivity for Cu(II) vs. Zn(II), were evaluated.
• Structure-activity relationships were investigated through systematic design modifications of Schiff base analogues.

Main Results:

• Electronic factors were found to be more influential than steric effects in determining chelator performance.
• Significant sensitivity of Cu(II)/Zn(II) selectivity to ring substituent effects was observed.
• Optimal selectivity was achieved through complementary electronic pairing, utilizing electron-donating groups on phenol rings and electron-withdrawing groups on pyridine rings.

Conclusions:

• Schiff base derivatives show potential as disease-modifying therapies for neurodegenerative conditions.
• Electronic modulation of chelator structure is crucial for achieving high therapeutic selectivity.
• This research provides a foundation for designing targeted chelators to combat metal-induced neurodegeneration.